Vaccinex, Inc. (NASDAQ:VCNX – Get Free Report) shares rose 9.9% during trading on Thursday . The company traded as high as $0.83 and last traded at $0.83. Approximately 161 shares traded hands during trading, a decline of 100% from the average daily volume of 57,098 shares. The stock had previously closed at $0.76.
Vaccinex Trading Up 9.9 %
The firm has a market capitalization of $2.17 million, a PE ratio of -0.02 and a beta of 1.10. The company has a fifty day moving average price of $0.82 and a two-hundred day moving average price of $1.76.
About Vaccinex
Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.
Read More
- Five stocks we like better than Vaccinex
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 2 Strong Utilities Plays With Booming Earnings and Room to Grow
- How to Choose Top Rated Stocks
- Why Smart Investors Don’t Panic in Election Season
- Expert Stock Trading Psychology Tips
- Now Is the Time to Buy ServiceNow—The Rebound Is Real
Receive News & Ratings for Vaccinex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaccinex and related companies with MarketBeat.com's FREE daily email newsletter.
